NEW YORK (Reuters Health) – People with mild to moderate COVID-19 who were treated with casirivimab and imdevimab – two monoclonal antibodies with emergency-use authorization for COVID-19 in the U.S. – had lower hospitalization rates than untreated counterparts in a retrospective study. Dr. Raymund Razonable of Mayo Clinic, in Rochester, […]
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01358-1/fulltext?utm_campaign=lancetcovid21&utm_content=169598491&utm_medium=social&utm_source=facebook&hss_channel=fbp-374651963469 Créditos: Comité científico Covid
The majority of vaccinated people who were admitted to hospital for covid-19 were probably infected shortly before or around the time of their vaccination, highlighting the importance of maintaining social distancing and understanding that immunity develops over time, researchers have said.1 The International Severe Acute Respiratory Infection Consortium Clinical Characterisation […]
The BNT162b2 mRNA vaccine from Pfizer–BioNTech and the ChAdOx1 nCoV-19 vaccine from Oxford–AstraZeneca were the first two products deployed in the UK’s COVID-19 vaccination programme. In accordance with the strategy set by the nation’s Joint Committee on Vaccination and Immunisation (JCVI), vaccines were initially prioritised for care home residents and […]
COVID-19 patients with ST-segment elevation myocardial infarction (STEMI) represent a high-risk population with unique demographic and clinical features resulting in a high risk for mortality, according to initial findings from the North American Cardiovascular COVID-19 Myocardial Infarction (NACMI) Registry. “This is the largest registry of COVID-positive patients presenting with STEMI [and] the […]
